Copy Number Variations of CEP63, FOSL2 and PAQR6 Serve as Novel Signatures for the Prognosis of Bladder Cancer

Copy Number Variations of CEP63, FOSL2 and PAQR6 Serve as Novel Signatures for the Prognosis of Bladder Cancer

BackgroundFinding effective prognostic signatures is of great urgency due to the high risk of recurrence and progression of bladder cancer (BC). Although a lot of genetic alterations are involved in the carcinogenesis, none of them were referred in the current risk group stratifications. In this stu...

Full description

Bibliographic Details
Main Authors: Zhao Cai, Huang Chen, Jingqiao Bai, Yang Zheng, Jianhui Ma, Xiongwei Cai, Yu Liu, Kaitai Zhang, Jianzhong Shou, Yanning Gao
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-05-01
Series:Frontiers in Oncology
Subjects:
copy number variation
bladder cancer
prognosis
CEP63
FOSL2
PAQR6
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.674933/full

Similar Items

Similar Items